Neuropsychiatric outcomes before and after switching to dolutegravir-based therapy in an acute HIV cohort.
Chan, Phillip
Neuropsychiatric outcomes before and after switching to dolutegravir-based therapy in an acute HIV cohort. [electronic resource] - AIDS research and therapy 01 2020 - 1 p. digital
Publication Type: Journal Article; Observational Study; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.
1742-6405
10.1186/s12981-019-0257-8 doi
Adult
Data Analysis
Drug Substitution--adverse effects
Female
HIV Infections--drug therapy
HIV Integrase Inhibitors--adverse effects
HIV-1--drug effects
Heterocyclic Compounds, 3-Ring--adverse effects
Humans
Longitudinal Studies
Male
Mental Disorders--etiology
Mood Disorders--etiology
Oxazines--adverse effects
Piperazines--adverse effects
Prospective Studies
Pyridones--adverse effects
Neuropsychiatric outcomes before and after switching to dolutegravir-based therapy in an acute HIV cohort. [electronic resource] - AIDS research and therapy 01 2020 - 1 p. digital
Publication Type: Journal Article; Observational Study; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.
1742-6405
10.1186/s12981-019-0257-8 doi
Adult
Data Analysis
Drug Substitution--adverse effects
Female
HIV Infections--drug therapy
HIV Integrase Inhibitors--adverse effects
HIV-1--drug effects
Heterocyclic Compounds, 3-Ring--adverse effects
Humans
Longitudinal Studies
Male
Mental Disorders--etiology
Mood Disorders--etiology
Oxazines--adverse effects
Piperazines--adverse effects
Prospective Studies
Pyridones--adverse effects